MétaCan
Menu
Back to cohort
Record W4412882053 · doi:10.3389/fonc.2025.1600821

A proof-of-concept study of personalized dosimetry for targeted radioligand therapy using pre-treatment diagnostic dynamic PET/CT and Monte Carlo simulation

2025· article· en· W4412882053 on OpenAlexaff
Danny De Sarno, Hatim Fakir, Glenn Bauman, Martin Martinov, Rowan M. Thomson, Ting‐Yim Lee

Bibliographic record

VenueFrontiers in Oncology · 2025
Typearticle
Languageen
FieldMedicine
TopicProstate Cancer Treatment and Research
Canadian institutionsLawson Health Research InstituteCarleton UniversityRobarts Clinical TrialsWestern University
Fundersnot available
KeywordsVoxelMonte Carlo methodRadioligandProstate cancerDosimetryNuclear medicineMedicineRadiologyCancerMathematicsInternal medicineStatistics

Abstract

fetched live from OpenAlex

Purpose Theranostics integrates diagnostic imaging (e.g., 18 F-PSMA-1007 PET) with targeted radioligand therapy (TRT; e.g., 177 Lu-PSMA-617), but personalized dosimetry remains challenging due to complex dose calculations. Current methods like Monte Carlo simulations are accurate but require impractical post-treatment multi-day SPECT/CT imaging. Here we establish a proof-of-concept framework using pre-treatment PET/CT to predict TRT doses via graphical analysis and Monte Carlo modeling, eliminating the need for serial imaging. Our voxel-based approach demonstrates significant dose variations in prostate cancer patients under standard TRT with a one-size-fits-all radioligand dose, enabling pre-treatment dose personalization—a critical step toward precision radiotheranostics. Methods Dynamic PET/CT scans obtained with 18 F-DCFPyL over 22 min from six prostate cancer patients were used in this study. Tissue time-integrated activity (TIA), that is, the total number of decays from the accumulated radioligand, was calculated as the product of the area under the curve (AUC) of an extrapolated arterial time activity curve (TAC) and the Logan distribution volume (LDV) determined by graphical analysis of tissue TAC. The resulting 177 Lu-PSMA-617 TIA map, along with the CT-derived tissue geometry, density, and composition maps, were used to calculate the absorbed dose in the prostate tumor, overall prostate, and bone marrow in the femurs by egs_mird , a Monte Carlo-based absorbed dose calculation. Biological effective dose (BED) was calculated using the voxel-based absorbed dose and an extended radiobiological linear quadratic model accounting for dose rate, DNA repair, and clonal repopulation. Results Voxel-wise LDV graphical analysis demonstrated strong linearity, with an interpatient mean R 2 of 0.999973 ± 0.000047 (mean ± SD). Using a one-size-fits-all radioligand dosing approach, significant variations in absorbed dose were observed: 10.4 ± 4.9 Gy/GBq in tumors, 5.1 ± 0.7 Gy/GBq in normal prostate tissue, and 1.0 ± 0.3 Gy/GBq in bone marrow. These variations were influenced by differences in both LDV and arterial TACs among the patients—the former due to radioligand binding avidity and the latter to tumor burden and clearance rates. Conclusion We developed a framework for personalized TRT dose calculations using pre-treatment diagnostic PET/CT scans, eliminating the need for post-treatment SPECT/CT scans via the LDV-based method. This approach addresses variability in tumor and organ-at-risk doses from one-size-fits-all radioligand dosing, enabling optimized pre-treatment planning and integration with external beam radiation therapy (EBRT) or brachytherapy, if indicated, for precise and effective therapy. This method shows promise but requires further validation through larger studies and direct comparison with post-treatment dosimetry to confirm its accuracy.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.627
Threshold uncertainty score0.434

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.025
GPT teacher head0.384
Teacher spread0.359 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations3
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueFrontiers in OncologySame topicProstate Cancer Treatment and ResearchFrench-language works237,207